U.S. stock futures were lower this morning, with the Dow futures falling around 400 points on Thursday.



Shares of Alto Neuroscience Inc (NYSE:ANRO) fell sharply in pre-market trading after the company announced topline data from its Phase 2 proof-of-concept clinical trial evaluating ALTO-101 did not achieve statistical significant on primary electroencephalography or cognitive endpoints versus placebo.



Alto Neuroscience shares dipped 13.6% to $20.16 in pre-market trading.



Here are some other stocks moving lower in pre-market trading.



<ul>
<li>Akso Health Group – ADR (NASDAQ:AHG) fell 9.4% to $2.10 in pre-market trading.</li>



<li>SharonAI Holdings Inc (NASDAQ:SHAZ) fell 8.8% to $25.19 in pre-market trading. SharonAI Holdings shares jumped around 22% on Wednesday after the company announced the signing of a five-year TCV AI infrastructure agreement with ESDS Software Solutions.</li>



<li>Progress Software Corp (NASDAQ:PRGS) fell 8.3% to $23.00 in pre-market trading.</li>



<li>Immunovant Inc (NASDAQ:IMVT) fell 8.3% to $23.02 in pre-market trading as the company announced Phase 3 study results for Batoclimab in Thyroid Eye Disease (TED).</li>



<li>Americas Gold and Silver Corporation (NYSE:USAS) fell 8.1% to $5.14 in pre-market trading after gaining 7% on Wednesday.</li>



<li>TRX Gold Corp (NYSE:TRX) fell 7.2% to $1.42 in pre-market trading.</li>



<li>Rezolve AI PLC (NASDAQ:RZLV) fell 7% to $2.91 in pre-market trading after jumping 22% on Wednesday.</li>



<li>Avino Silver &amp; Gold Mines Ltd (NYSE:ASM) fell 6% to $6.20 in pre-market trading after gaining 4% on Wednesday.</li>
</ul>



Photo via Shutterstock

LABD

U.S. stock futures are down, with the Dow futures falling 400 points. Alto Neuroscience shares dropped 13.6% after disappointing Phase 2 trial results. Other stocks also fell in pre-market trading, including Akso Health Group (-9.4%), SharonAI Holdings (-8.8%), Progress Software (-8.3%), and Immunovant (-8.3%).

benzinga_article

Direxion S&P Biotech Bear 3X

Akso Health

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

iShares Biotechnology ETF

Immunovant

Ark Genomic Revolution ETF

Alto Neuroscience

First Trust NYSE Arca Biotech Index Fd

Direxion S&P Biotech Bull 3X

Proshares Ultra Nasdaq Biotech

SharonAI

SPDR S&P Biotech

ALPS Medical Breakthrough

VG Health

VanEck Biotech ETF

Progress Software

Alto Neuroscience, Immunovant And Other Big Stocks Moving Lower In Thursday's Pre-Market Session